worth noting the warning itself isn't saying these drugs are unsafe across the board - regulatory agencies flag potential signals all the time, and then real-world data either confirms or doesn't confirm the concern. with glp-1s, we're talking about millions of people using them now, so even genuinely rare side effects will surface. the eye disorder cases reported seem to cluster in people with certain risk factors, particularly those with existing diabetes complications, so if you're considering these drugs your doctor would weigh your individual situation anyway. the risk-benefit calculation looks pretty different depending on whether you're using it for weight loss versus managing type 2 diabetes, which most folks don't really distinguish when they're talking about "people on ozempic.